Humacyte, Inc.·4

Apr 15, 4:03 PM ET

Scheessele William John 4

4 · Humacyte, Inc. · Filed Apr 15, 2025

Insider Transaction Report

Form 4
Period: 2025-04-14
Scheessele William John
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2025-04-14$1.54/sh+6,493$9,99922,018 total

Documents

1 file
  • 4
    wk-form4_1744747408.xmlPrimary

    FORM 4